NeuroSigma Launches ADHD Trial for Children with FAS Using Monarch eTNS
April 30, 2025
Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) NeuroSigma, Inc., a Los Angeles-based bioelectronics